Caption Management, LLC
Position in MLYS — Mineralys Therapeutics, Inc.
CIK 1706766
OKLAHOMA CITY, OK
Position in MLYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,145,087
+$11,145,087 QoQ
Shares Held
413,087
Ownership
0.467%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#52
of 224 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Derivatives in MLYS
reported options exposure · as of Jun 30, 2026CallValue
$3,879,724
CallShares
143,800
PutValue
$22,976,168
PutShares
851,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. MLYS ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
This page
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in MLYS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,976,168 | 851,600 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $11,145,087 | 413,087 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $3,879,724 | 143,800 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $47,440,008 | 1,751,200 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $41,236,398 | 1,522,200 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $44,542,346 | 1,227,400 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $44,339,122 | 1,221,800 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $12,134,400 | 320,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $492,960 | 13,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $446,490 | 33,000 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $676,500 | 50,000 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $3,933,476 | 247,700 | Call | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||